Regencell Bioscience Holdings Limited Stock
Equities
RGC
KYG7487R1002
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.56 USD | -10.61% | +4.32% | -47.05% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 300M |
---|---|---|---|---|---|
Net income 2022 | -7M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 15.65M | Net cash position 2023 | 11.1M | EV / Sales 2023 | - |
P/E ratio 2022 |
-59.5
x | P/E ratio 2023 |
-51.1
x | Employees | 12 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.24% |
1 day | -10.61% | ||
1 week | +4.32% | ||
Current month | +5.50% | ||
1 month | +46.32% | ||
3 months | -25.13% | ||
6 months | -62.68% | ||
Current year | -47.05% |
Managers | Title | Age | Since |
---|---|---|---|
Wai Hong Chung
COO | Chief Operating Officer | 46 | - |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
Yat-Pui Au
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wing Yan Lo
BRD | Director/Board Member | 63 | 21-12-12 |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-09-30 |
- | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 5.56 | -10.61% | 970 |
24-05-08 | 6.22 | +4.02% | 2,117 |
24-05-07 | 5.98 | +12.20% | 1,601 |
24-05-03 | 5.33 | -17.87% | 5,282 |
Delayed Quote Nasdaq, May 09, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-47.05% | 72.35M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RGC Stock